论文部分内容阅读
目的探讨急性胰腺炎患者早期ERCP及内镜治疗应用的价值及安全性.方法急性胰腺炎患者作早期(1d~7d内)ERCP及内镜治疗(ERCP组,66例),并以同期保守治疗的急性胰腺炎患者60例作对照(对照组),观察两组患者血清淀粉酶恢复时间,腹痛缓解时间、住院天数、住院费用及并发症发生情况.结果ERCP组中,36例为胆道疾病患者,4例为胰管结石,4例为胰腺分裂症,3例为乳头旁巨大憩室,17例ERCP未见异常.作内镜下治疗33例,其中EPT及取石术17例,4例作了副乳头切开及扩张术,12例作了鼻胆管引流术.ERCP组腹痛缓解天数及平均住院天数分别为115d±36d及217d±50d,明显短于对照组(154d±78d及330d±68d,P<001).血清淀粉酶恢复时间及住院费用两组相差不显著.两组均未发生严重并发症.结论急性胰腺炎早期ERCP及内镜治疗经济安全、有效,可缩短腹痛缓解时间及住院天数,作者认为对胆源性胰腺炎应尽早行ERCP及内镜治疗.
Objective To investigate the value and safety of early ERCP and endoscopic treatment in patients with acute pancreatitis. Methods The acute pancreatitis patients were treated with ERCP and endoscopic therapy (ERCP group, 66 cases) early and 60 cases of acute pancreatitis (control group) Amylase recovery time, abdominal pain relief time, hospitalization days, hospitalization costs and complications. Results Among the ERCP group, 36 cases were diagnosed as biliary tract disease, 4 cases were pancreatic duct stones, 4 cases were pancreatic schizophrenia, 3 cases were giant papillary diverticulum, and 17 cases were abnormal in ERCP. Endoscopic treatment for 33 cases, of which 17 cases of EPT and lithotomy, 4 cases of deputy nipple incision and expansion, 12 cases of nasobiliary drainage. The days of abdominal pain relief and average length of stay in ERCP group were 115 ± 36 d and 217 ± 50 d, respectively, which were significantly shorter than those in control group (154 ± 78 days and 330 ± 68 days, P <001). Serum amylase recovery time and hospitalization costs were not significantly different between the two groups. No serious complications occurred in either group. Conclusion Early ERCP and endoscopic treatment of acute pancreatitis is economical and effective, and can shorten the time and length of hospital stay. The author believes ERCP and endoscopic treatment of biliary pancreatitis should be performed as soon as possible.